Paper8467484
Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis.
Murakami H and 5 others. Cancer Res, 1993. Cited by 243 papers, by iCite.
Cite this record
ConductScience Library. Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis. Papers, record 8467484. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8467484
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cocarcinogenesis | Major topic |
| Genes, myc | Major topic |
| Liver Neoplasms, Experimental | Major topic |
| Transforming Growth Factor alpha | Major topic |
| Animals | |
| Cell Nucleus | |
| Cell Transformation, Neoplastic | |
| Disease Models, Animal | |
| Gene Expression | |
| Male | |
| Mice | |
| Mice, Transgenic | |
| Zinc |
Source PubMed
Cited by104
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 243 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42759661 | Molecular mechanism of augmentation of oncogenic activity of MYC by TAF2 in HCC. | J Biol Chem | 2026 | https://conductscience.org/library/papers/42759661 | PubMed |
| 41704422 | Co-administered internalizing RGD peptide boosts anti-PD-L1 therapy in hepatocellular carcinoma. | JHEP Rep | 2026 | https://conductscience.org/library/papers/41704422 | PubMed |
| 40741108 | The application of liver cancer organoids in tumour precision medicine: A comprehensive review. | ILIVER | 2025 | https://conductscience.org/library/papers/40741108 | PubMed |
| 39062197 | Preclinical Models of Hepatocellular Carcinoma: Current Utility, Limitations, and Challenges. | Biomedicines | 2024 | https://conductscience.org/library/papers/39062197 | PubMed |
| 38889481 | Tumour-specific activation of a tumour-blood transport improves the diagnostic accuracy of blood tumour markers in mice. | EBioMedicine | 2024 | https://conductscience.org/library/papers/38889481 | PubMed |
| 38138981 | New and Old Key Players in Liver Cancer. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/38138981 | PubMed |
| 36982773 | Assessment of the Pharmacokinetics, Disposition, and Duration of Action of the Tumour-Targeting Peptide CEND-1. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36982773 | PubMed |
| 36403194 | WD repeat domain 48 promotes hepatocellular carcinoma progression by stabilizing c-Myc. | J Cell Mol Med | 2022 | https://conductscience.org/library/papers/36403194 | PubMed |
| 35847898 | Mouse Models of Hepatocellular Carcinoma: Classification, Advancement, and Application. | Front Oncol | 2022 | https://conductscience.org/library/papers/35847898 | PubMed |
| 35633441 | Molecular targeted drugs, comprehensive classification and preclinical models for the implementation of precision immune oncology in hepatocellular carcinoma. | Int J Clin Oncol | 2022 | https://conductscience.org/library/papers/35633441 | PubMed |
| 35053588 | Hepatocellular Carcinoma Is a Natural Target for Adeno-Associated Virus (AAV) 2 Vectors. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35053588 | PubMed |
| 35008356 | A Shortcut from Metabolic-Associated Fatty Liver Disease (MAFLD) to Hepatocellular Carcinoma (HCC): c-MYC a Promising Target for Preventative Strategies and Individualized Therapy. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/35008356 | PubMed |
| 34771745 | In Vivo and In Vitro Models of Hepatocellular Carcinoma: Current Strategies for Translational Modeling. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34771745 | PubMed |
| 34758313 | Single-cell transcriptomics reveals opposing roles of Shp2 in Myc-driven liver tumor cells and microenvironment. | Cell Rep | 2021 | https://conductscience.org/library/papers/34758313 | PubMed |
| 34464659 | TAZ is indispensable for c-MYC-induced hepatocarcinogenesis. | J Hepatol | 2022 | https://conductscience.org/library/papers/34464659 | PubMed |
| 34353442 | Astrocyte elevated gene-1 (AEG-1): A key driver of hepatocellular carcinoma (HCC). | Adv Cancer Res | 2021 | https://conductscience.org/library/papers/34353442 | PubMed |
| 32489910 | A method to establish a c-Myc transgenic mouse model of hepatocellular carcinoma. | MethodsX | 2020 | https://conductscience.org/library/papers/32489910 | PubMed |
| 32327473 | Mouse Models of Oncoimmunology in Hepatocellular Carcinoma. | Clin Cancer Res | 2020 | https://conductscience.org/library/papers/32327473 | PubMed |
| 32160703 | Validation of miR-20a as a Tumor Suppressor Gene in Liver Carcinoma Using Hepatocyte-Specific Hyperactive piggyBac Transposons. | Mol Ther Nucleic Acids | 2020 | https://conductscience.org/library/papers/32160703 | PubMed |
| 31861541 | Genetically Engineered Mouse Models for Liver Cancer. | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/31861541 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8467484
GET https://conductscience.org/api/papers/v1/8467484/cited_by?page=2